Details for: NALOXONE HYDROCHLORIDE INJECTION, USP


Product description

Product name: NALOXONE HYDROCHLORIDE INJECTION, USP

Company name: EUGIA PHARMA INC.

DIN: 02534975

Status: Approved

Status date: 2023-02-06

Active ingredient(s) Strength
NALOXONE HYDROCHLORIDE 4 MG / 10 ML

Resources

Click on a resource to visit a page with more information. You may be taken away from this page to a different Government of Canada website.

Resource Description
Report a side effect

Side effects are troublesome symptoms or feelings that you may not expect that show up when you are taking a medicine.

All suspected side effects should be reported, especially those that are:

  • Unexpected, regardless of their severity, i.e., not consistent with product information or labelling; or
  • Serious, whether expected or not, i.e., that requires being admitted to the hospital, lengthened hospital stay, causes a birth defect, disability, is life-threatening or results in death;
  • Reactions to recently marketed health products (on the market for less than five years), regardless of their nature or severity.

Resource Description
Report a side effect

Side effects are troublesome symptoms or feelings that you may not expect that show up when you are taking a medicine.

All suspected side effects should be reported, especially those that are:

  • Unexpected, regardless of their severity, i.e., not consistent with product information or labelling; or
  • Serious, whether expected or not, i.e., that requires being admitted to the hospital, lengthened hospital stay, causes a birth defect, disability, is life-threatening or results in death;
  • Reactions to recently marketed health products (on the market for less than five years), regardless of their nature or severity.